Granted Patent
B2
US 9,895,383 · App. 15/354,862 · Granted Feb 20, 2018
Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
Assignee:
ANTECIP BIOVENTURES II LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Oral dosage forms of osteoclast inhibitors, such as nitrogen-containing bisphosphonates, can be used to treat or alleviate pain or related conditions such as complex regional pain syndrome.
Claims (4)
1. A method of treating pain associated with complex regional pain syndrome comprising orally administering zoledronic acid in an acid form or a salt form to a human being having complex regional pain syndrome, wherein the complex regional pain syndrome is associated with an inciting traumatic event.
2. The method of claim 1 , wherein the zoledronic acid is in a salt form.
3. The method of claim 1 , wherein the zoledronic acid is in an acid form.
4. The method of claim 1 , wherein the inciting traumatic event is a fracture.
Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 14, 2017
From: TABUTEAU, HERRIOT
To: ANTECIP BIOVENTURES II LLC
Reel/Frame 041570/0113 →
Continuity (20)
Continuation In Part
PCTUS2015032739
· May 27, 2015
Provisional Application
61803721
· Mar 20, 2013
Provisional Application
61767676
· Feb 21, 2013
Provisional Application
61767647
· Feb 21, 2013
Provisional Application
61764563
· Feb 14, 2013
Provisional Application
61762225
· Feb 7, 2013
Provisional Application
61655541
· Jun 5, 2012
Provisional Application
61655527
· Jun 5, 2012
Provisional Application
61654383
· Jun 1, 2012
Provisional Application
61654292
· Jun 1, 2012
Provisional Application
61647478
· May 15, 2012
Provisional Application
61646538
· May 14, 2012